prescription drugs
-
PublishedJanuary 22, 2022
Another View: Lifetime bans a fitting punishment for ‘Pharma Bro’ and his ilk
Martin Shkreli would jack up the price of lifesaving drugs all over again if he had the chance.
-
PublishedNovember 19, 2021
Commentary: Focus on hearing aids, not a questionable Alzheimer’s drug
Alzheimer’s groups will help far more people by promoting hearing aids and a healthy lifestyle than by touting Aduhelm.
-
PublishedNovember 10, 2021
Maine Voices: There is a state-level solution to high prescription drug costs
Other states have passed laws regulating pharmacy reimbursements. Why not Maine?
-
PublishedNovember 9, 2021
Oklahoma court overturns $465 million opioid ruling against Johnson & Johnson
The Oklahoma Supreme Court weighed whether the company’s marketing and sale of opioids created a public nuisance.
-
PublishedNovember 2, 2021
Democrats reach deal on lowering drug prices; Biden upbeat on Manchin
Democrats are looking to cap out-of-pocket Medicare drug costs at $2,000 and reduce the price of insulin, as part of President Biden's $1.75 trillion domestic policy proposal.
-
PublishedJuly 29, 2021
Our View: Opioid settlement funds must address addiction crisis
Deals are being reached with the companies responsible for shipping habit-forming medications across the U.S., and the proceeds must be used wisely.
-
PublishedJuly 2, 2021
Commentary: The Alzheimer’s mistake by the FDA is already getting worse
Now drugmaker Eli Lilly is pushing forward with another unproven treatment on the basis of limited evidence.
-
PublishedJune 23, 2021
Commentary: Medicare must study unproven, expensive Alzheimer’s drug
Taxpayers and patients cannot afford to pay a high price for a treatment not known to be effective.
-
PublishedJune 17, 2021
Commentary: Generic prescriptions deliver savings for Maine patients
An op-ed and an editorial praising proposed state regulations overlook the fact that brand-name drugs are consistently more costly to Maine.
-
PublishedJune 12, 2021
Another View: Alzheimer’s drug furor highlights U.S. health system’s failures
Is aducanumab a breakthrough or a boondoggle? U.S. health policy offers reason to worry.
- ← Previous Page
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- Next Page →